Locations:
Search
An international consensus statement on a subtype of a rare disease
Increased invasive disease-free survival, disease-free survival and overall survival
New recommendations for second-line therapy
Research has clear implications for future of prostate cancer imaging
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Trial may lead to first FDA approval in this realm
Complimentary case-based program Aug. 24
New adjuvant therapies, advances in neoadjuvant
Two Cleveland Clinic physicians lead the way
A breast oncologist’s answer
New evidence supports ART, but caveats remain
Advertisement
Advertisement